CV Sciences (CVSI) Short-term Investments (2016 - 2021)
CV Sciences (CVSI) posted Short-term Investments of $501000.0 for Q2 2021, little changed sequentially from $501000.0 in Q1 2021, and little changed YoY from $501000.0 in Q2 2020.
CV Sciences (CVSI) Short-term Investments (2016 - 2021) Analysis & Trends
CV Sciences has reported Short-term Investments for 6 years, with the latest figure at $501000.0 in Q2 2021.
- Quarterly Short-term Investments changed 0.0% year-over-year to $501000.0 in Q2 2021, while the trailing twelve-month figure through Jun 2021 was $501000.0 (changed 0.0% YoY) and the FY2020 annual result came in at $501000.0, changed 0.0% from the prior year.
- Short-term Investments was little changed at $501000.0 in Q2 2021 per CVSI's latest filing, from $501000.0 in the prior quarter.
- Over five years, Short-term Investments peaked at $1.1 million in Q1 2017 and troughed at $251000.0 in Q4 2018.
- A 5-year average of $626045.7 and a median of $501000.0 in 2019 frame the typical range for Short-term Investments.
- The sharpest annual moves came in 2017 and 2018: Short-term Investments jumped 182.49% in 2017, then plunged 67.76% in 2018.
- Over 5 years, Short-term Investments stood at $778579.0 in 2017, then plunged by 67.76% to $251000.0 in 2018, then surged by 99.6% to $501000.0 in 2019, then changed by 0.0% to $501000.0 in 2020, then changed by 0.0% to $501000.0 in 2021.
- According to Business Quant data, Short-term Investments over the past three periods registered $501000.0, $501000.0, and $501000.0 for Q2 2021, Q1 2021, and Q4 2020 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 501,000.00 |
| Mar 31, 2021 | 501,000.00 |
| Dec 31, 2020 | 501,000.00 |
| Sep 30, 2020 | 501,000.00 |
| Jun 30, 2020 | 501,000.00 |
| Mar 31, 2020 | 501,000.00 |
| Dec 31, 2019 | 501,000.00 |
| Sep 30, 2019 | 500,000.00 |
| Jun 30, 2019 | 500,000.00 |
| Dec 31, 2018 | 251,000.00 |
| Sep 30, 2018 | 738,356.00 |
| Jun 30, 2018 | 778,579.00 |
| Mar 31, 2018 | 781,310.00 |
| Dec 31, 2017 | 778,579.00 |
| Sep 30, 2017 | 750,185.00 |
| Jun 30, 2017 | 940,653.00 |
| Mar 31, 2017 | 1.12 Mn |
| Dec 31, 2016 | 275,611.00 |